Urtica at CPHI Milan 2026 – international partnerships and pharmaceutical distribution in Poland
From 6 to 8 October 2026, we attended CPHI Milan, an international pharmaceutical trade fair, as an exhibitor for the first time. We presented international pharmaceutical manufacturers with opportunities to work with Urtica on sales, hospital-market support and pharmaceutical distribution in Poland.
In this article, you will learn:
- which topics shaped our discussions with manufacturers at CPHI Milan 2026,
- how Urtica supports pharmaceutical manufacturers in the Polish market,
- which of Urtica’s project has reached the final of the CPHI Pharma Awards 2026.
CPHI MILAN 2026
The Polish pharmaceutical market at the centre of discussions
During the three days of the trade fair, we held a number of scheduled meetings as well as numerous additional discussions with representatives of the pharmaceutical industry. These covered both the launch of new products on the Polish market and the development of sales and distribution of medicines already available in Poland.
We discussed, first and foremost, the specific characteristics of the Polish hospital market, sales organisation, tender procedures and models of cooperation with a local pharmaceutical distributor in Poland.
We also devoted a significant part of our discussions to specialist and innovative products, including orphan medicines and projects requiring a bespoke approach to the organisation of the sale and distribution of medicines.
01 07
COOPERATION WITH MANUFACTURERS
Urtica – a partner for international pharmaceutical manufacturers on the Polish healthcare market
Participation in CPHI provided an opportunity to showcase Urtika’s experience in collaborating with foreign manufacturers of generic, as well as original and innovative, medicines.
As a Polish distributor of medicines and a full-line pharmaceutical wholesaler, we work with all hospitals across the country. We support manufacturers in organising the sale and distribution of medicinal products. Our activities include, amongst other things, market analysis, handling hospital tenders, cooperation with medical facilities, warehousing, stock and delivery planning, and logistics solutions for products requiring special storage and transport conditions.
We tailor the scope of our cooperation to the specific nature of the product, the manufacturer’s needs and the conditions of the Polish market. This applies both to the regular supply of hospitals and to projects relating to the introduction of new therapies and non-standard models of pharmaceutical distribution in Poland.
AN EXPERT'S VIEW
“We are delighted that, during our first appearance as an exhibitor, we were able to welcome so many industry representatives to our stand. We are committed to developing international cooperation and strengthening Urtika’s position as a partner for foreign pharmaceutical manufacturers on the Polish market.”
Ewelina Przybyłek
International Market Manager at Urtica
CPHI PHARMA AWARDS
Urtica is among the finalists for the CPHI Pharma Awards 2026
At CPHI Milan 2026, we were also named among the five finalists for the CPHI Pharma Awards in the ‘Excellence with Purpose’ category. The shortlisted project, ‘Named patient import when every dose matters’, concerned the import of a specific medicinal product.
The product had been authorised for sale in the US, but did not have marketing authorisation in the European Union. Due to unforeseen and exceptional circumstances, the Urtika team had to coordinate the receipt and dispatch of the product at very short notice and organise an overnight delivery.
The scale of our day-to-day distribution is one aspect of our business. Equally important is our readiness to handle tailored, non-standard projects, where efficient organisation and turnaround times are crucial for the patient in question.
AN EXPERT'S VIEW
“We had very little time to coordinate all the activities. It was crucial to organise the receipt and dispatch of the product efficiently and to ensure good cooperation between those involved at each stage. Situations like this demonstrate how important experience and clearly defined procedures are, but above all, people who understand the gravity of the situation and are prepared to step up when it is needed.”
Adam Wasiak
International Cooperation Coordinator at Urtica
OUTLOOK
Further opportunities for collaboration
We left Milan with new contacts, opportunities for further cooperation and a sense of time well spent.
We would like to thank everyone who visited our stand and took the time to have a chat with us.